Who will be included?

About 100 HIV+ patients on suppressive antiretroviral therapy with hypertension and hypercholesterolemia from each site will be included, with a total of 300 participants.

Who is doing the study?

The study is sponsored by National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI). Dr. Chris Longenecker and Dr. Allison Webel at Case Western Reserve University will lead the study and MetroHealth Medical Center and Duke University Medical Center are two additional participating sites.